Company intelligence / Profile preview

Biostem US

Pompano Beach, Florida, United States

Ownership: Private
Employees: ~33
Development stage: Other

Overview

BioStem Technologies is a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived allografts for advanced wound care. The company leverages its proprietary BioREtain® processing method to manufacture perinatal tissue allografts while preserving natural growth factors and tissue structure.

Therapeutic areas: CardiovascularEndocrinologyDermatologyRheumatologyPulmonology
Modalities: AllograftBiologicCell therapy
Industry: Biotech

Beyond the preview

Go deeper on Biostem US.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biostem US.

Explore the full profile